Embrace the Insanity<br />By Rev Shark<br />RealMoney.com Contributor<br />3/24/2010 8:38 AM EDT<br /><br /> "I would be willing, yes glad, to see a battle every day during my life."<br /><br /> -- George Armstrong Custer <br /><br />The market has been in rally mode for about six weeks now. It hit a low on Feb. 5 and has gone straight up since then. It is almost impossible to come up with new adjectives to describe how remarkable this run has been.<br /><br />It isn't the point gain that is so unusual; it's the consistency of the action. According to Sentimentrader.com, the longest period of selling pressure during this six-week run is just four hours. In other words, the total market correction over a month and a half of trading is half of a day. I don't know if that is a record, but it must be pretty close.<br /><br />What makes trading both so fascinating and frustrating is the irrationality of the market beast. The best traders in the world are going to be surprised quite often at the action, and trying to apply logic is a recipe for disaster more often than not.<br /><br />If you want to be successful in the market, you have to able to embrace the craziness of the market beast. The action may make no sense to us at all, but we can't make money by trying to overpower what may feel irrational to us.<br /><br />The primary job of the market beast is to make things difficult for us. He'll give us some lay-ups in a while, just to make sure we stay in the game, but ultimately, what he wants to do is drive us nuts and take our cash.<br /><br />Fortunately, we can still do quite well in the battle with the beast if we stay persistent and disciplined. The great advantage is that we can do battle every day, and we are given an endless number of opportunities to score points. As long as we have capital left, we can keep playing the game, and if you are disciplined in using stops and taking profits, you can play forever.<br /><br />I'm not going to go into how overbought and how badly we need a rest again this morning. Anyone paying the slightest bit of attention to the market already knows it. We are still walking the high-wire, and so far, there has hardly been a wobble in the ascent. Don't fight this beast, but stay vigilant and disciplined. The one thing we know for sure about the market is that conditions will eventually change.<br /><br />We have a little weakness on a downgrade of Portugal debt, which is hitting the euro and causing the dollar to rise. Economic reports should give us a jiggle, but it is going to take something pretty severe to scare away the dip-buyers, who haven't had a dip that has lasted longer than four hours in the past six weeks. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: MF +12.0% (also appoints Jon Corzine Chairman and Chief Executive Officer), LEN +6.7%, AIS +5.3% (light volume), ADBE +4.1% ... Other news: GENT +20.9% (announces Defibrotide results at EBMT Annual Meeting; 40% reduction in the incidence of VOD within 30 days after SCT ), OCNF +12.0% (announces an order for three VLOCs), XFN +8.0% (issues letter to shareholders indicating it has been awarded $63.6 mln in stimulus grants and long term loans from USDA), NVAX +6.8% (announces "Positive" clinical results from first stage of pivotal study of 2009 A/H1N1 VLP Pandemic Influenza Vaccine in Mexico), USU +4.9% (USEC and DOE Fund continued American Centrifuge activities), S +4.4% (Sprint Nextel and HTC Corporation announced summer availability of the world's first 3G/4G Android handset, HTC EVO 4G), NTDOY +3.6% (light volume; Nintendo plans 3-D hand-held - WSJ), PHM +2.4% (up in sympathy with LEN), SOMX +1.9% (still checking), COP +1.3% (takes steps to increase shareholder value; announces plan to increase dividends, reduce LUKOIL ownership, and resume share repurchases)... Analyst comments: FCH +13.0% (upgraded to Outperform at FBR), JEC +1.8% (upgraded to Overweight at JPMorgan), CNX +1.2% (upgraded to Overweight at JPMorgan), HNZ +0.7% (upgraded to Neutral from Underperform at BofA/Merrill).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: LIME -15.2%, PUDA -15.0%, JBL -5.2%, SONC -4.9% (also downgraded to Sell at Stifel Nicolaus), CHU -4.4%, CMC -1.8%... Select financial related names trading lower: CS -3.4%, UBS -2.9%, HBC -2.6%, DB -1.4%, .... Select metals/mining names showing weakness: BBL -3.2%, BHP -2.9%, MT -2.5%, SLW -2.4%, AU -2.3%, ALV -2.2%, NEM -2.1%, GDX -1.9%, GOLD -1.8%, KGC -1.8%, GG -1.8%, ABX -1.7%, RTP -1.1%, GLD -0.9%... Select Portugal/Spain related names trading lower following Fitch downgrade of Portugal: STD -4.8%, PT -3.9% (Fitch Downgrades Portugal to 'AA-'; Outlook Negative), TEF -1.7%... Select oil/gas related names showing weakness: E -2.4%, TOT -2.1%, RDS.A -1.9%, STO -1.8%, BP -1.3%, PBR -1.3%... Other news: PARD -20.5% (suspends efforts to obtain regulatory approval for picoplatin in SCLC; has engaged Leerink Swann to conduct a review of strategic alternatives), MDTH -9.4% (still checking), BOCH -9.1% (priced a 7.2 mln share common stock offering at $4.25/share), ORRF -6.6% (prices 1,481,481 common shares at $27.00/share), GENZ -5.4% (announces FDA enforcement action regarding Allston plant; expects shipments of Cerezyme, Fabrazyme and Myozyme to continue uninterrupted ), TKC -4.9% (still checking), CX -4.5% (announced a $500 mln convertible notes offering), NETL -4.4% (filed for a ~5.89 mln share common stock offering; 3.2 mln shares will be offering by the co and the remainder will be offered by selling shareholders), ERIC -3.9% (traded lower overseas; China Unicom is ERIC customer and reported earnings), PAY -3.1% (still checking), DT -2.5% (T-Mobile to boost U.S. network - WSJ), GFA -2.0% (Hearing weakness attributed to pricing of offering), LSI -1.5% (Integrated Device receives favorable ruling in patent action versus LSI Logic), LINE -1.0% (prices 15.0 mln units of its limited liability company interests at $25.00/unit), MEE -0.8% (announces pricing of 8.5 mln share offering at $49.75), ... Analyst comments: TWTC -4.2% (downgraded to Hold from Buy at Collins Stewart), SRCL -2.8% (downgraded to Neutral at JPMorgan), DT -2.5% (downgraded to Neutral at Credit Suisse), NRG -1.1% (removed from Conviction Buy List at Goldman).